Arsenale Bioyards develops a bio-manufacturing platform that integrates advanced hardware, AI-driven software and precision fermentation to help industries develop and scale bio-based alternatives to petrochemicals and animal-derived products. The company operates a fully functioning pilot site with 1,000L precision fermentation capacity, including two advanced 500L bioreactors and a suite of smaller bioreactors with industry-first sensing capabilities. Led by CEO Massimo Portincaso and a senior technical team, Arsenale targets customers across food, chemicals and materials and is accelerating commercialization in the food and cosmetics industries. It has operations in Pordenone and the US in addition to its Milan base. The company closed a seed financing to fund infrastructure expansion and to advance its commercialization roadmap.

Total raised

$10M

Funding rounds

1

Latest round

Seed

Latest activity

Feb 2025